股本结构
单位:万股
公告日期 | 2024-04-09 | 2024-04-09 | 2024-01-09 | 2024-01-09 | 2023-10-04 | 2023-10-04 |
---|---|---|---|---|---|---|
证券总股本 | 77402.86 | 77402.81 | 74272.51 | 73290.76 | 73028.96 | 73028.26 |
普通股本 | 77402.86 | 77402.81 | 74272.51 | 73290.76 | 73028.96 | 73028.26 |
优先股 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
其他 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
变动日期 | 2024-04-05 | 2024-02-29 | 2024-01-05 | 2023-11-30 | 2023-10-02 | 2023-09-20 |
注释:中概股证券总股本=普通股股本/
存托凭证比例
历史变动
公告日期 | 变动后普通股本(万股) | 变动后优先股(万股) | 变动原因 | 变动日期 |
---|---|---|---|---|
2024-04-09 | 77402.86 | 未披露 | 定期报告 | 2024-04-05 |
2024-04-09 | 77402.81 | 未披露 |
更多>>
From November 30, 2023 to February 29, 2024
Share issuance - RSUs exercised
Share issuance - Repurchase of APHA 24 convertible note
Share issuance - Double Diamond Holdings dividend settlement
Share issuance - options exercised
|
2024-02-29 |
2024-01-09 | 74272.51 | 未披露 | 定期报告 | 2024-01-05 |
2024-01-09 | 73290.76 | 未披露 |
更多>>
From August 31, 2023 to November 30, 2023
Share issuance - HTI convertible note
Share issuance - Settlement of litigation claims from MediPharm Labs Inc
Share issuance - Repurchase of TLRY 23 convertible note
Share issuance - RSUs exercised
|
2023-11-30 |
2023-10-04 | 73028.96 | 未披露 | 定期报告 | 2023-10-02 |
2023-10-04 | 73028.26 | 未披露 | 定期报告 | 2023-09-20 |
2023-09-27 | 72328.26 | 未披露 | 定期报告 | 2023-09-15 |
2023-10-04 | 72329.26 | 未披露 |
更多>>
From May 31, 2023 to August 31, 2023
Share issuance - HEXO acquisition
Share issuance - RSUs exercised
Share issuance - settlement of contractual change of control severance incurred from HEXO acquisition
Share issuance - HTI convertible note
Share issuance - Double Diamond Holdings dividend settlement
|
2023-08-31 |
2023-07-26 | 70325.72 | 未披露 | 定期报告 | 2023-07-24 |
2023-07-26 | 65665.55 | 未披露 |
更多>>
From May 31, 2022 to May 31, 2023
Share issuance - equity financing
Share issuance- purchase of HEXO convertible note receivable
Share issuance - Double Diamond Holdings note
Share issuance - convertible notes share lending agreement
|
2023-05-31 |
2023-04-10 | 61800.79 | 未披露 | 定期报告 | 2023-04-03 |
2023-04-10 | 61785.70 | 12.00 |
更多>>
From November 30, 2022 to February 28, 2023
Share issuance - RSUs exercised
Share issuance - Double Diamond Holdings note
Preferred share issuance
|
2023-02-28 |
2023-01-09 | 61549.46 | 未披露 | 定期报告 | 2023-01-05 |
2023-01-09 | 61318.16 | 未披露 |
更多>>
From August 31, 2022 to November 30, 2022
Shares issued to purchase Montauk
Share issuance - options exercised
Share issuance - RSUs exercised
Share issuance - Double Diamond Holdings note
|
2022-11-30 |
2022-10-03 | 61140.23 | 未披露 | 定期报告 | 2022-09-26 |
2022-10-07 | 60095.49 | 未披露 |
更多>>
From May 31, 2022 to August 31, 2022
Shares issued to purchase HEXO convertible note receivable
Share issuance - Double Diamond Holdings note
Share issuance - equity financing
Share issuance - RSUs exercised
Share issuance - options exercised
|
2022-08-31 |
2022-08-03 | 58000.49 | 未披露 | 定期报告 | 2022-08-03 |
2022-07-28 | 53639.08 | 未披露 | 定期报告 | 2022-07-22 |
2022-07-28 | 53267.49 | 未披露 |
更多>>
From May 31, 2021 to May 31, 2022
Share issuance - Superhero Acquisition LP
Share issuance - Breckenridge Acquisition
Share issuance - equity financing
Share issuance - Double Diamond Holdings note
Share issuance - legal settlement
Share issuance - purchase of capital and intangible assets
Share issuance - options exercised
Share issuance - RSUs exercised
|
2022-05-31 |
2022-04-12 | 45816.73 | 未披露 | 定期报告 | 2022-04-12 |
2022-04-06 | 49770.85 | 未披露 | 定期报告 | 2022-04-05 |
2022-04-06 | 48073.75 | 未披露 |
更多>>
From November 30, 2021 to February 28, 2022
Share issuance - Breckenridge Acquisition
Share issuance - legal settlement
Share issuance - options exercised
Share issuance - RSUs exercised
Share issuance - purchase of capital and intangible assets
|
2022-02-28 |
2022-03-03 | 48072.43 | 未披露 | 定期报告 | 2022-02-17 |
2022-01-10 | 46652.26 | 未披露 | 定期报告 | 2022-01-04 |
2022-01-10 | 46380.24 | 未披露 |
更多>>
From August 31, 2021 to November 30, 2021
Share issuance - Superhero Acquisition LP
Share issuance - DDH note
Share issuance - options exercised
Share issuance - RSUs exercised
Share-based payments, net
|
2021-11-30 |
2021-10-07 | 46065.87 | 未披露 | 定期报告 | 2021-10-04 |
2021-09-24 | 46043.26 | 未披露 | 定期报告 | 2021-09-24 |
2021-10-07 | 45052.35 | 未披露 |
更多>>
From May 31, 2021 to August 31, 2021
Share issuance - options exercised
Share issuance - RSUs exercised
|
2021-08-31 |
2021-07-28 | 44922.08 | 未披露 | 定期报告 | 2021-07-22 |
2021-06-25 | 44916.56 | 未披露 | 定期报告 | 2021-06-22 |
2021-07-28 | 44644.06 | 未披露 |
更多>>
From May 31, 2020 to May 31, 2021
Share issuance - legal settlement
Share issuance - equity financing
Share issuance - SweetWater acquisition
Share issuance - contract settlement
Share issuance - Arrangement
Share issuance - options exercised
Share issuance - RSUs exercised
|
2021-05-31 |
2021-05-13 | 44737.13 | 未披露 | 定期报告 | 2021-05-07 |
2021-05-06 | 44644.06 | 未披露 | 定期报告 | 2021-04-30 |
2021-04-28 | 17935.22 | 未披露 | 定期报告 | 2021-04-23 |
2021-05-10 | 17911.90 | 未披露 |
更多>>
From December 31, 2020 to March 31, 2021
Escrow shares released from downstream merger
Shares issued for common stock at-the-market, net of issuance costs
Shares issued under stock-based compensation plans
Shares issued for exercise of warrants
|
2021-03-31 |
2021-03-12 | 17884.16 | 未披露 | 定期报告 | 2021-03-12 |
2021-02-19 | 17175.77 | 未披露 | 定期报告 | 2021-02-17 |
2021-02-19 | 15845.61 | 未披露 |
更多>>
From December 31,2019 to December 31,2020
Escrow shares released from downstream merger
Shares issued under registered offering, net of issuance costs
Shares issued for exercise of pre-funded warrants
Shares issued for investments
Shares issued under stock-based compensation plans
Shares issued for common stock at-the-market, net of issuance costs
Shares issued for contract settlements
Shares issued for convertible debt settlement
|
2020-12-31 |
2021-03-12 | 15825.68 | 未披露 | 定期报告 | 2020-12-15 |
2020-11-09 | 13352.63 | 未披露 | 定期报告 | 2020-11-09 |
2020-11-09 | 13328.99 | 未披露 |
更多>>
From June 30, 2020 to September 30, 2020
Shares issued for common stock at-the-market, net of issuance costs
Shares issued under stock-based compensation plans
Shares issued for contract settlement
|
2020-09-30 |
2020-08-10 | 12717.76 | 未披露 | 定期报告 | 2020-08-10 |
2020-08-10 | 12593.14 | 未披露 |
更多>>
From March 31, 2020 to June 30, 2020
Escrow shares released from downstream merger
Shares issued for common stock at-the-market, net of issuance costs
Shares issued under stock-based compensation plans
|
2020-06-30 |
2020-05-11 | 12486.19 | 未披露 | 定期报告 | 2020-05-11 |
2020-04-29 | 12468.62 | 未披露 | 定期报告 | 2020-04-28 |
2020-05-11 | 12464.35 | 未披露 |
更多>>
From December 31, 2019 to March 31, 2020
Escrow shares released from downstream merger
Shares issued for common stock at-the-market, net of issuance costs
Shares issued for investments
Shares issued under stock-based compensation plans
Shares issued under registered offering, net of issuance costs
Shares issued for exercise of pre-funded warrants
|
2020-03-31 |
2020-04-30 | 12465.41 | 未披露 | 定期报告 | 2020-03-30 |
2020-03-17 | 11003.12 | 未披露 |
更多>>
Tilray, Inc. announced today that it has priced an underwritten registered offering of 7,250,000 shares of its Class 2 common stock and, in lieu of Class 2 common stock, pre-funded warrants to purchase 11,750,000 shares of Class 2 common stock, and accompanying warrants to purchase 19,000,000 shares of its Class 2 common stock (or, for investors who so choose, pre-funded warrants to purchase shares of Class 2 common stock) at a price to the public of $4.76 per share and accompanying warrant (or $4.7599 per pre-funded warrant and accompanying warrant). The offering is expected to close on March 17, 2020, subject to customary closing conditions.
|
2020-03-17 |
2020-03-02 | 10405.68 | 未披露 | 定期报告 | 2020-03-02 |
2020-03-02 | 10278.12 | 未披露 |
更多>>
From December 31, 2018 to December 31, 2019
Shares issued for Natura acquisition
Shares issued for Natura contingent consideration
Shares issued for Manitoba Harvest acquisition
Shares issued for ABG Profit Participation Arrangement
Shares issued for common stock at-the-market, net of issuance costs
Shares issued for investments
Shares issued for S & S acquisition
Shares issued under stock-based compensation plans
Shares issued for employee compensation
Downstream merger
|
2019-12-31 |
2019-11-13 | 10050.77 | 未披露 | 定期报告 | 2019-11-13 |
2019-11-13 | 10027.17 | 未披露 |
更多>>
From June 30, 2019 to September 30, 2019
Shares issued for common stock at-the-market, net of issuance costs
Shares issued for Manitoba Harvest acquisition
Shares issued for investments and S&S acquisition
Shares issued under stock-based compensation plans
|
2019-09-30 |
2019-09-11 | 9856.14 | 未披露 | 定期报告 | 2019-09-09 |
2019-08-13 | 9764.50 | 未披露 | 定期报告 | 2019-08-13 |
2019-08-13 | 9735.75 | 未披露 |
更多>>
From March 31, 2019 to June 30, 2019
Shares issued under stock-based compensation plans
Shares issued for investment acquisition
|
2019-06-30 |
2019-05-15 | 9723.11 | 未披露 | 定期报告 | 2019-05-15 |
2019-05-15 | 9679.82 | 未披露 |
更多>>
From December 31, 2018 to March 31, 2019
Shares issued for Natura acquisition
Shares issued for Manitoba Harvest acquisition
Shares issued for ABG Profit Participation Arrangement
Shares issued under stock option plans
Shares issued for employee compensation
|
2019-03-31 |
2019-03-25 | 9679.22 | 未披露 | 定期报告 | 2019-03-25 |
2019-03-25 | 9317.09 | 未披露 |
更多>>
from December 31, 2017 to December 31, 2018
Issuance of convertible preferred stock, net of issuance costs
Conversion of convertible preferred stock
Issuance of common stock, net of issuance cost
Issuance of shares for Alef acquisition
|
2018-12-31 |
2018-11-14 | 9316.48 | 未披露 | 定期报告 | 2018-11-14 |
2018-11-14 | 9314.40 | 未披露 | 定期报告 | 2018-09-30 |
2018-08-29 | 9314.40 | 未披露 | 定期报告 | 2018-08-29 |
2018-07-19 | 9179.40 | 未披露 |
更多>>
1.Class 2 common stock offered 9,000,000 shares
2.The number of shares of Class 2 common stock to be outstanding after this offering is based on 66,127,375 shares of Class 2 common stock outstanding as of March 31, 2018
|
2018-07-19 |
2018-06-20 | 7500.00 | 779.40 |
更多>>
from December 31, 2017 to March 31, 2018
Issuance of convertible preferred stock net of issuance costs (unaudited)
Issuance of common stock (unaudited)
|
2018-03-31 |
From November 30, 2023 to February 29, 2024
Share issuance - RSUs exercised
Share issuance - Repurchase of APHA 24 convertible note
Share issuance - Double Diamond Holdings dividend settlement
Share issuance - options exercised
From August 31, 2023 to November 30, 2023
Share issuance - HTI convertible note
Share issuance - Settlement of litigation claims from MediPharm Labs Inc
Share issuance - Repurchase of TLRY 23 convertible note
Share issuance - RSUs exercised
From May 31, 2023 to August 31, 2023
Share issuance - HEXO acquisition
Share issuance - RSUs exercised
Share issuance - settlement of contractual change of control severance incurred from HEXO acquisition
Share issuance - HTI convertible note
Share issuance - Double Diamond Holdings dividend settlement
From May 31, 2022 to May 31, 2023
Share issuance - equity financing
Share issuance- purchase of HEXO convertible note receivable
Share issuance - Double Diamond Holdings note
Share issuance - convertible notes share lending agreement
From November 30, 2022 to February 28, 2023
Share issuance - RSUs exercised
Share issuance - Double Diamond Holdings note
Preferred share issuance
From August 31, 2022 to November 30, 2022
Shares issued to purchase Montauk
Share issuance - options exercised
Share issuance - RSUs exercised
Share issuance - Double Diamond Holdings note
From May 31, 2022 to August 31, 2022
Shares issued to purchase HEXO convertible note receivable
Share issuance - Double Diamond Holdings note
Share issuance - equity financing
Share issuance - RSUs exercised
Share issuance - options exercised
From May 31, 2021 to May 31, 2022
Share issuance - Superhero Acquisition LP
Share issuance - Breckenridge Acquisition
Share issuance - equity financing
Share issuance - Double Diamond Holdings note
Share issuance - legal settlement
Share issuance - purchase of capital and intangible assets
Share issuance - options exercised
Share issuance - RSUs exercised
From November 30, 2021 to February 28, 2022
Share issuance - Breckenridge Acquisition
Share issuance - legal settlement
Share issuance - options exercised
Share issuance - RSUs exercised
Share issuance - purchase of capital and intangible assets
From August 31, 2021 to November 30, 2021
Share issuance - Superhero Acquisition LP
Share issuance - DDH note
Share issuance - options exercised
Share issuance - RSUs exercised
Share-based payments, net
From May 31, 2021 to August 31, 2021
Share issuance - options exercised
Share issuance - RSUs exercised
From May 31, 2020 to May 31, 2021
Share issuance - legal settlement
Share issuance - equity financing
Share issuance - SweetWater acquisition
Share issuance - contract settlement
Share issuance - Arrangement
Share issuance - options exercised
Share issuance - RSUs exercised
From December 31, 2020 to March 31, 2021
Escrow shares released from downstream merger
Shares issued for common stock at-the-market, net of issuance costs
Shares issued under stock-based compensation plans
Shares issued for exercise of warrants
From December 31,2019 to December 31,2020
Escrow shares released from downstream merger
Shares issued under registered offering, net of issuance costs
Shares issued for exercise of pre-funded warrants
Shares issued for investments
Shares issued under stock-based compensation plans
Shares issued for common stock at-the-market, net of issuance costs
Shares issued for contract settlements
Shares issued for convertible debt settlement
From June 30, 2020 to September 30, 2020
Shares issued for common stock at-the-market, net of issuance costs
Shares issued under stock-based compensation plans
Shares issued for contract settlement
From March 31, 2020 to June 30, 2020
Escrow shares released from downstream merger
Shares issued for common stock at-the-market, net of issuance costs
Shares issued under stock-based compensation plans
From December 31, 2019 to March 31, 2020
Escrow shares released from downstream merger
Shares issued for common stock at-the-market, net of issuance costs
Shares issued for investments
Shares issued under stock-based compensation plans
Shares issued under registered offering, net of issuance costs
Shares issued for exercise of pre-funded warrants
Tilray, Inc. announced today that it has priced an underwritten registered offering of 7,250,000 shares of its Class 2 common stock and, in lieu of Class 2 common stock, pre-funded warrants to purchase 11,750,000 shares of Class 2 common stock, and accompanying warrants to purchase 19,000,000 shares of its Class 2 common stock (or, for investors who so choose, pre-funded warrants to purchase shares of Class 2 common stock) at a price to the public of $4.76 per share and accompanying warrant (or $4.7599 per pre-funded warrant and accompanying warrant). The offering is expected to close on March 17, 2020, subject to customary closing conditions.
From December 31, 2018 to December 31, 2019
Shares issued for Natura acquisition
Shares issued for Natura contingent consideration
Shares issued for Manitoba Harvest acquisition
Shares issued for ABG Profit Participation Arrangement
Shares issued for common stock at-the-market, net of issuance costs
Shares issued for investments
Shares issued for S & S acquisition
Shares issued under stock-based compensation plans
Shares issued for employee compensation
Downstream merger
From June 30, 2019 to September 30, 2019
Shares issued for common stock at-the-market, net of issuance costs
Shares issued for Manitoba Harvest acquisition
Shares issued for investments and S&S acquisition
Shares issued under stock-based compensation plans
From March 31, 2019 to June 30, 2019
Shares issued under stock-based compensation plans
Shares issued for investment acquisition
From December 31, 2018 to March 31, 2019
Shares issued for Natura acquisition
Shares issued for Manitoba Harvest acquisition
Shares issued for ABG Profit Participation Arrangement
Shares issued under stock option plans
Shares issued for employee compensation
from December 31, 2017 to December 31, 2018
Issuance of convertible preferred stock, net of issuance costs
Conversion of convertible preferred stock
Issuance of common stock, net of issuance cost
Issuance of shares for Alef acquisition
1.Class 2 common stock offered 9,000,000 shares
2.The number of shares of Class 2 common stock to be outstanding after this offering is based on 66,127,375 shares of Class 2 common stock outstanding as of March 31, 2018
from December 31, 2017 to March 31, 2018
Issuance of convertible preferred stock net of issuance costs (unaudited)
Issuance of common stock (unaudited)